Chongqing Diabetes Registry Study

NCT03692884 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2023-09-06

No results posted yet for this study

Summary

To investigate the risk factors and biomarkers of the microvascular disease,macrovascular disease and neuropathy in patients with diabetes.

Conditions

Sponsors & Collaborators

  • Chongqing Medical University

    lead OTHER

Principal Investigators

  • Qifu Li, phD · First Affiliated Hospital of Chongqing Medical University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2030-07-01
Completion
2030-07-01

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03692884 on ClinicalTrials.gov